PD-1 checkpoint inhibitor (GigaGen)

N/A

Report date: 2025/03/20 15:32:15

Base Information

Drug NamePD-1 checkpoint inhibitor (GigaGen)

Drug Alias NamePD-1 checkpoint inhibiting chimeric antibodies (GigaGen)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionProgrammed cell death protein 1 blockers

TargetsProgrammed cell death protein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGigaGen Inc

China Registration ClassN/A

Develop Information

Active CompaniesGigaGen Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A